BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18533580)

  • 1. Fatality due to amisulpride toxicity: a case report.
    Lynch MJ; Woods J; George N; Gerostamoulos D
    Med Sci Law; 2008 Apr; 48(2):173-7. PubMed ID: 18533580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes.
    Isbister GK; Murray L; John S; Hackett LP; Haider T; O'Mullane P; Gosselin S; Daly F
    Med J Aust; 2006 Apr; 184(7):354-6. PubMed ID: 16584372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
    Isbister GK; Balit CR; Macleod D; Duffull SB
    J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of torsade de pointes from the QT interval: analysis of a case series of amisulpride overdoses.
    Joy JP; Coulter CV; Duffull SB; Isbister GK
    Clin Pharmacol Ther; 2011 Aug; 90(2):243-5. PubMed ID: 21716272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amisulpride poisoning: a report on two cases.
    Tracqui A; Mutter-Schmidt C; Kintz P; Berton C; Mangin P
    Hum Exp Toxicol; 1995 Mar; 14(3):294-8. PubMed ID: 7779461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.
    Berling I; Isbister GK
    Ann Emerg Med; 2015 Aug; 66(2):154-64. PubMed ID: 25639523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [QT prolongation and second-generation antipsychotics: overdose and therapeutic dosage].
    Trojak B; Pinoit JM; Disson-Dautriche A; Bonin B; Giusselmann A
    Therapie; 2004; 59(5):558-61. PubMed ID: 15648310
    [No Abstract]   [Full Text] [Related]  

  • 8. Amisulpride overdose: suggested management of prolonged QTc.
    Stevenson RJ
    Emerg Med J; 2010 Jul; 27(7):565. PubMed ID: 20584965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid high-performance liquid chromatographic measurement of amisulpride in human plasma: application to manage acute intoxication.
    Péhourcq F; Ouariki S; Bégaud B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 789(1):101-5. PubMed ID: 12726848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prolonged QT interval in two cases of amisulpride overdose].
    Barceló B; Yates C; Castanyer B; Puiguriguer J
    Med Clin (Barc); 2010 Apr; 134(12):564-5. PubMed ID: 19376545
    [No Abstract]   [Full Text] [Related]  

  • 12. [Torsades de pointes during sultopride poisoning].
    Montaz L; Varache N; Harry P; Aymes C; Turcant A; Delille F; Simonin D; Hass C
    J Toxicol Clin Exp; 1992 Dec; 12(8):481-6. PubMed ID: 1364061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Toxicity of sulpiride].
    Ciszowski K; Szpak D; Wilimowska J
    Przegl Lek; 2010; 67(8):606-9. PubMed ID: 21387787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal neuroleptic malignant syndrome due to amisulpride.
    Musshoff F; Doberentz E; Madea B
    Forensic Sci Med Pathol; 2013 Jun; 9(2):218-20. PubMed ID: 23504701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amisulpride poisoning. A case report].
    Roussel O; Dumillard C; Sadeg N; Belhadj Tahar H
    Therapie; 2006; 61(6):534-6. PubMed ID: 17348611
    [No Abstract]   [Full Text] [Related]  

  • 16. Schizophrenia, antipsychotic drugs, and cardiovascular disease.
    Glassman AH
    J Clin Psychiatry; 2005; 66 Suppl 6():5-10. PubMed ID: 16107178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study.
    la Fougère C; Meisenzahl E; Schmitt G; Stauss J; Frodl T; Tatsch K; Hahn K; Möller HJ; Dresel S
    J Nucl Med; 2005 Jun; 46(6):1028-33. PubMed ID: 15937316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma amisulpride levels in schizophrenia or schizoaffective disorder.
    Bergemann N; Kopitz J; Kress KR; Frick A
    Eur Neuropsychopharmacol; 2004 May; 14(3):245-50. PubMed ID: 15056484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-mortem antipsychotic drug concentrations and unexplained deaths.
    Jusic N; Lader M
    Br J Psychiatry; 1994 Dec; 165(6):787-91. PubMed ID: 7881780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic bradycardia associated with amisulpride.
    Pedrosa Gil F; Grohmann R; Rüther E
    Pharmacopsychiatry; 2001 Nov; 34(6):259-61. PubMed ID: 11778148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.